Jyothy Labs — Q4 FY26 earnings call

Call held 4 May 2026

Management summary

Jyothy Labs reported a mixed Q4 FY26, with strong volume growth in Fabric Care and Personal Care segments, and significant loss reduction in Household Insecticides. However, profitability was impacted by elevated input costs and intense competition, leading to a 400 bps decline in gross margin and 330 bps in EBITDA margin. The company remains debt-free with a healthy cash balance and is actively pursuing M&A opportunities while navigating an uncertain demand and cost environment.

Highlights

  • FY26 revenue grew 3.5% in value and 6% in volumes, demonstrating steady volume growth despite headwinds.

  • Fabric Care segment showed strong performance in Q4 FY26 with 14.4% value growth and 17.8% volume growth, led by liquid detergents.

  • Personal Care segment recovered well, achieving 20% value and volume growth in Q4 FY26.

  • Household Insecticides (HI) segment significantly reduced losses from INR25 crores last year to INR5 crores this year, moving closer to profitability.

  • Net working capital improved to 15 days, a reduction of 4 days, and the company maintains a debt-free status with a strong cash balance of INR1,000 crores.

Concerns

  • Gross margin for Q4 FY26 was 45.2%, down 400 basis points year-on-year, primarily due to input cost inflation and lower realizations.

  • EBITDA margin for Q4 FY26 stood at 13.5%, a decline of 330 basis points year-on-year.

  • Input costs, especially crude-linked inputs (LAB, PP, PE) and packaging materials, increased sharply towards the end of the year, putting pressure on the overall cost structure.

  • Dishwash segment value growth remained flat in Q4 FY26 despite 5% volume growth, attributed to intense competition, price cuts, and higher grammage.

  • The demand environment remains uncertain, with potential impacts on consumer spending due to elevated inflation and geopolitical developments.

Key financials

2 periods

Q4 FY26

  • Revenue
    ₹717 Cr
    YoY +7.7%
  • Gross Margin
    45.2%
    YoY -4%
  • EBITDA Margin
    13.5%
    YoY -3.3%

FY26

  • Revenue
    ₹2,944 Cr
    YoY +3.5%
  • Gross Margin
    47%
    YoY -3.2%
  • EBITDA Margin
    15.3%
    YoY -2.3%
  • PAT
    ₹333 Cr

What they filed

Q4 FY25: revenue up 1.1%, net profit down 2.6% against the same quarter last year.

₹ Cr · quarterly
Line itemQ1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue687 732 678 660 742 +8%734 +0%704 +4%667 +1%
EBITDA117 135 119 108 133 +14%138 +2%116 −3%112 +4%
Net profit96 104 91 78 102 +6%105 +1%87 −4%76 −3%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

SegmentValue GrowthVolume Growth
Fabric Care (FY26)8%9.5%
Fabric Care (Q4 FY26)14.4%17.8%
Dishwash (FY26)-1.3%6%
Personal Care (FY26)5%1.6%
Personal Care (Q4 FY26)20%20%
Household Insecticides (HI) (FY26)——
Household Insecticides (HI) (Q4 FY26)3%—

Capital allocation

high confidence
  • Capex Capex disclosed
    And sir, capex for '27, will it be similar to previous year or a bit higher? Similar. It will be in similar range only. Yes. Thank you.
  • Debt Debt disclosed
    We remain debt free with a strong cash balance of INR1,000 crores.
  • Dividend ₹3.5/share (final)
    The Board has recommended a final dividend of INR3.5 per share for FY26.
  • Liquidity Cash ₹1,000 Cr Company is debt-free and actively scouting for acquisitions.
    We remain debt free with a strong cash balance of INR1,000 crores.

Guidance & targets

Profitability

  • Tax Rate Profitability · FY27 · High confidence 25-26%
    It will be, we will be going for 115BAA. So, rate should be around 25% to 26%. It should be hovering between 25% to 26%.

    — Pawan Agarwal

  • HI Segment Profitability Profitability · earlier than FY27 · Medium confidence earlier than FY27

    Previously FY27 → earlier than FY27

    but it seems that if the last two quarters are anything to go by, I think we are on the right track and probably it can help us deliver the profitability target much earlier.

    — Pawan Agarwal

Capex

  • Capex Capex · FY27 · Medium confidence similar to previous year
    Similar. It will be in similar range only. Yes. Thank you.

    — Pawan Agarwal

Margins

  • Overall Margin Guidance Margins · FY27 · Low confidence difficult to give
    At this stage, we will be constrained to give any guidance on margin front. Maybe once the external environment settles down a little bit, hopefully, it should in a couple of quarters' time, then we'll be able to guide the street on our margin target for FY27.

    — Pawan Agarwal

  • Q1 FY27 Margin Pressure Margins · Q1 FY27 · High confidence some pressure
    For the current quarter, there will be some pressure on margins.

    — Pawan Agarwal

Growth

  • Volume vs Value Growth Gap Growth · Going forward · Medium confidence narrow down and slowly converge
    I think the gap between volume and value growth would narrow down and slowly it will converge.

    — Pawan Agarwal

What to watch in Q1 FY27

Q1 FY27 Margin Trajectory

Next quarter (Q1 FY27 results)
Current Q4 FY26 EBITDA margin 13.5%, gross margin 45.2%, with management expecting 'some pressure' in Q1.
Target Stabilization or improvement in margins, or further compression.

Why it matters

Margins were a key concern in Q4, and management indicated continued pressure in Q1, making their trajectory critical for profitability outlook.

For the current quarter, there will be some pressure on margins.

Risks & concerns

  • Input Cost Inflation

    high

    Crude prices, packaging costs (LAB, PP, PE) moved up sharply, impacting overall cost structure, with full impact difficult to pass on immediately.

    Management acknowledged

  • Margin Pressure

    high

    Gross and EBITDA margins compressed in Q4 due to input costs and lower realizations, with management expecting continued pressure in Q1 FY27.

    Management acknowledged

  • Demand Uncertainty

    medium

    Urban demand was uneven, and the West Asia situation adds unpredictability, posing a risk to consumer spending and rural demand if farm income is impacted.

    Management acknowledged

  • Competitive Intensity

    medium

    High competition in Dishwash and liquid detergent segments led to price reductions, grammage increases, and pressure on realizations.

    Management acknowledged

Q&A highlights

6 direct, 1 evasive
Fabric Care liquid detergent market share and growth strategy Direct
So, the thing is that we've been investing on the brands, and that has helped us yield that result. And it's not just on detergent, liquid detergents, it's across the Fabric Care portfolio also.

Analyst inquired about capitalizing on the powder-to-liquid conversion trend and new product launches, to which management affirmed strong performance due to brand investment.

Asked by Vishal Gutka

Dishwash segment margins and competitive intensity Direct
So, for Exo bar user, if you see, there are not much choice for Exo bar consumer in liquid. So, for any Exo bar users to upgrade, it was high time to launch Exo Liquid. So that is one. Exo Liquid is antibacterial and it has bio-enzymes, Pril is more on degreasing and on premium liquid segment. So that is the differentiation, and we wish to see that both the brands grow, we'll be investing on both the brands, yes.

Analyst questioned the margin compression in Dishwash and the strategy for new Exo Liquid, prompting management to explain differentiation and market capture strategy.

Asked by Vishal Gutka

HI segment long-term growth and profitability path Direct
And we had indicated that by the end of FY27, this category will be profitable, but it seems that if the last two quarters are anything to go by, I think we are on the right track and probably it can help us deliver the profitability target much earlier.

Analyst sought clarity on the future of the HI segment, and management provided an updated, more optimistic timeline for profitability.

Asked by Vishal Gutka

Cash balance and M&A activity Direct
Yes, you are right, and we have been scouting for right assets. And very aggressively, we are looking for right asset. But as we have mentioned earlier, we are going to pick up the asset, which actually adds to the overall shareholders' value. And we are in active dialogues with a couple of them.

Analyst questioned the utilization of the INR1,000 crores cash balance, and management confirmed active pursuit of value-accretive M&A opportunities.

Asked by Vishal Gutka

Overall margin guidance for FY27 Evasive
At this stage, we will be constrained to give any guidance on margin front. Maybe once the external environment settles down a little bit, hopefully, it should in a couple of quarters' time, then we'll be able to guide the street on our margin target for FY27.

Analyst pressed for FY27 margin guidance, but management declined due to high market volatility, indicating uncertainty for investors.

Asked by Vishal Gutka

Brand differentiation compared to competition Partial
Yes. Certainly, what I'm saying is each brand has a different positioning. So, it's what the brand speaks is what the brand delivers. That is where it is. So, we are differentiated.

Analyst sought a deeper understanding of the company's brand differentiation strategy, to which management provided a general statement without specific examples.

Asked by Rushabh Shah

Impact of input cost inflation on margins and pricing actions Direct
good question, Percy. There are two reasons for this. One is, of course, some bit of inflation did hit us in quarter 4. But on the pricing side, lower overall lower sales realization has also impacted margin. As you know, we have a typical 2 to 3 months of lag between the cost increases on the input side and the price action that we take on the sales side.

Analyst questioned the significant margin drop in Q4 despite typical inventory cover, leading management to explain the combined effect of inflation, lower realizations, and competitive actions.

Asked by Percy

Magnitude of price increases and unaddressed inflation Direct
No, I cannot give that number just now. But we are monitoring the price increases on the raw material side on a continuous basis. And depending upon the market situation and also the volume growth or ambition, we have to keep all the factors in mind while taking any pricing decisions.

Analyst asked for specific figures on price increases and remaining inflation, to which management confirmed a 4% portfolio-wide increase but refrained from quantifying the unaddressed inflation due to dynamic market conditions.

Asked by Akash Shah

2 min read 6 chapters

Detailed narrative

Q4 FY26 and Full Year FY26 Performance Overview

Jyothy Labs reported Q4 FY26 revenue of INR717 crores, marking a 7.7% year-on-year increase. For the full fiscal year 2026, the company achieved revenues of INR2,944 crores, growing 3.5% in value terms and 6% in volumes. Despite a volatile FMCG environment and elevated input costs, the company maintained steady volume growth, supported by strategic grammage actions and a gradual improvement in demand during the second half of the financial year.

Profitability Impacted by Input Costs and Competition

The company's profitability faced headwinds in Q4 FY26, with gross margin at 45.2%, down 400 basis points year-on-year, and EBITDA margin at 13.5%, a 330 basis point decline. This was primarily driven by sharp increases in crude-linked input costs such as LAB, PP, and PE, which account for 50-60% of inputs, and packaging costs (15-20% of material costs). Management noted a typical 2-3 month lag between cost increases and pricing actions, expecting continued margin pressure in Q1 FY27.

Segmental Growth Dynamics

Fabric Care demonstrated strong growth in Q4 FY26, with 14.4% value and 17.8% volume growth, driven by liquid detergents. Personal Care also showed a robust recovery, achieving 20% growth in both value and volume in Q4, with the Margo franchise performing well. The Household Insecticides (HI) segment saw a 3% value growth in Q4 and significantly reduced its full-year losses from INR25 crores to INR5 crores, moving closer to profitability ahead of schedule.

Competitive Landscape and Pricing Strategies

The Dishwash segment experienced intense competition, leading to flat value growth in Q4 despite a 5% volume increase, due to price reductions and higher grammage. Jyothy Labs launched Exo Liquid, differentiated by bio-enzymes, to compete directly with market leaders and offer an upgrade path for Exo bar users. The company maintains its market share across categories by ensuring competitive pricing and focusing on brand quality and differentiation.

Capital Allocation and M&A Outlook

Jyothy Labs maintains a strong financial position, being debt-free with a cash balance of INR1,000 crores. The Board recommended a final dividend of INR3.5 per share for FY26. The company is actively scouting for suitable M&A targets that align with its strategic goals and add shareholder value, confirming active dialogues with potential targets. Capex for FY27 is expected to be similar to the previous year, and the tax rate is projected to be 25-26%.

Future Outlook and Market Conditions

Management anticipates FY27 to be a stronger year, with a focus on scaling new product developments, improving general trade productivity, and sustaining volume growth amidst price hikes. However, uncertainty persists regarding demand conditions and input costs, making it difficult to provide specific margin guidance for FY27. The company expects the gap between volume and value growth to narrow down and slowly converge due to strategic pricing actions.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Fast Moving Consumer Goods earnings calls